Skip to content

FP7H2020HORIZON

Bernhard-Nocht-Institut fuer Tropenmedizin

Country
DEGermany
Defence projects
0
Projects, all programmes
33
As coordinator
9
EU contribution (CORDIS)
EUR 16,358,088
Active
2008 to 2025

Projects

33 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
DEFENDERIdentification of novel viral entry factors and development of antiviral approachesHORIZON2025ParticipantEUR 1,263,111
ASAAP-plusClinical evaluation of AntimalarialS tri-therapy with AtovAquone-Proguanil for treatment of uncomplicated malaria in African childrenHORIZON2024CoordinatorEUR 454,069
EVORAEuropean Viral Outbreak Response AllianceHORIZON2024ParticipantEUR 61,188
eWHORMEnabling the WHO-Roadmap 2030HORIZON2023ParticipantEUR 522,250
INTEGRATEThe Integrate study : An adaptive platform trial for the development of a new intervention to combat Lassa fever in AfricaHORIZON2023ParticipantEUR 1,939,750
MARVAXDevelopment of novel viral vectored vaccines against Marburgviruses inducing robust and cross-reactive protectionHORIZON2023CoordinatorEUR 1,730,506
MOBILISEMOBILISE: A novel and green mobile One Health laboratory for (re-)emerging infectious disease outbreaksHORIZON2022CoordinatorEUR 1,240,135
ISIDOReIntegrated Services for Infectious Disease Outbreak ResearchHORIZON2022ParticipantEUR 10,500
EPIC-CROWN-2Equine Polyclonal antibodies Immunotherapy against COVID-19/SARS-CoV2–VOCHORIZON2021ParticipantEUR 550,875
MALARTCellular basis of Artemisinin resistance in malaria parasitesH20202021CoordinatorEUR 2,388,243
ISOLDAImproved Vaccination Strategies for Older AdultsH20202020ParticipantEUR 617,911
e-shapeEuroGEO Showcases: Applications Powered by EuropeH20202019ParticipantEUR 29,975
ERINHA-AdvanceAdvancing European Research Infrastcuture on Highly Pathogenic AgentsH20202019ParticipantEUR 43,750
PEVIAPAN EBOLA VACCINE INNOVATIVE APPROACH – Sofia ref.: 116088H20202017ParticipantEUR 182,500
EBOPATHEvaluation of species-specific ebolavirus pathophysiology in xenochimeric miceH20202016CoordinatorEUR 71,442
ZIKAllianceA global alliance for Zika virus control and preventionH20202016ParticipantEUR 87,983
MofinaMobile Filovirus Nucleic Acid Test – Sofia ref.: 115848H20202015ParticipantEUR 217,992
EVAgEuropean Virus Archive goes globalH20202015ParticipantEUR 650,537
EbolaVacDevelopment of a Chimpanzee Adenovirus Type 3 Ebolavirus Zaire VaccineH20202014ParticipantEUR 107,500
REACTIONEvaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) during Ebola virus infection in non-human primates humansH20202014ParticipantEUR 64,250

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.